… caused by SARS-COV-2 virus of the coronavirus Family. The … active site of SARS-CoV-2
main protease was carried out. … with the active site of SARS-CoV-2 main protease enzyme. …

… these assays are still performant to detect the virus that has evolved … silico for 11 primers
and probe sets using the bioinformatics tool SCREENED and 84,305 representative SARS-CoV-…

… serological study on SARS-CoV-2 proteins using LISP 4 and compared to our in-silico
predictions (Table 1). The experimental data appeared to validate our in-silico predictions for Nuc, …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of
people across the globe and created not only a health emergency but also a financial crisis. …

… Many suppliers declare the ability of their test to in silico detect the viral variants that were
circulating and included in freely available repositories (eg, NCBI Genbank and GISAID) at the …

… silico study were obtained in the wet lab by Chan and colleagues, who detected SARS-CoV …
RdRp gene that is considered strictly specific to SARS-CoV-2 [30]. This indicates that our in …

… COVID-19 is a pandemic disease caused by novel corona virus, SARS-CoV-2, initially …
that have a high avidity against SARS-CoV-2 antibodies to detect infections by COVID-19. …

… detect many viral variants is imperative. In this work, we identified 26 conserved segments
(CS) in the SARS-CoV… We extended the analyses to include 211,833 SARS-CoV-2 sequences …

… In this study, the in silico sensitivity of 12 RT-qPCR tests (containing 30 primers and probe
sets) developed for detection of SARS-CoV-2 was assessed for detecting SARS-CoV-2 BA.4 …

SARS-Cov-2(Covid-19) is a new strain of coronavirus and was firstly emerged in December
2019 in Wuhan, China. Now, there is no known specific treatment of Covid-19 available. …